Influence of polymeric carrier on the disposition and retention of 20(R)-ginsenoside-rg3-loaded swellable microparticles in the lung

Drug Deliv Transl Res. 2018 Feb;8(1):252-265. doi: 10.1007/s13346-017-0456-6.

Abstract

The objective of this study was to investigate the influence of differently charged biocompatible polymers, including chitosan (CS), hyaluronic acid (HA), and hydroxypropyl cellulose (HPC), on the disposition and retention of 20(R)-ginsenoside-rg3 (Rg3)-loaded swellable microparticles in the lung. A high-pressure homogenization method combined with spray drying was used to prepare Rg3-loaded microparticles. In vitro aerodynamic performance of different microparticles was characterized by the Next Generation Impactor (NGI). Retention of the swellable microparticles in the rat lung was investigated using bronchoalveolar lavage fluid method. Influence of drug loading, polymer molecular weight, and polymer charge on the properties of the swellable microparticles was investigated. It was found that drug loading had no significant influence on experimental mass median aerodynamic diameter (MMADe) and fine particle fraction (FPF). Increasing polymer molecular weight caused no remarkable change in MMADe value, but the FPF value decreased with the increase of polymer molecular weight. At the same molecular weight level, polymer structure and charge had no statistical influence on the in vitro aerodynamic properties of the microparticles and lung disposition, but it influenced the swelling and bioadhesion behavior and therefore lung retention profile. Desirable phagocytosis escapement and inhibition of A549 cell proliferation were achieved for the developed swellable microparticles. In conclusion, the lung retention of swellable microparticles can be adjusted by selecting polymeric carriers with different structure and charge.

Keywords: 20(R)-ginsenoside-rg3; A549 cells; Chitosan; Hyaluronic acid; Hydroxypropyl cellulose; Lung disposition and retention; Swellable microparticle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Adhesiveness
  • Animals
  • Bronchoalveolar Lavage Fluid / chemistry
  • Cell Survival / drug effects
  • Cellulose / administration & dosage
  • Cellulose / analogs & derivatives*
  • Cellulose / chemistry
  • Cellulose / pharmacokinetics
  • Chitosan / administration & dosage*
  • Chitosan / chemistry
  • Chitosan / pharmacokinetics
  • Drug Carriers / administration & dosage*
  • Drug Carriers / chemistry
  • Drug Carriers / pharmacokinetics
  • Drug Liberation
  • Ginsenosides / administration & dosage*
  • Ginsenosides / chemistry
  • Ginsenosides / pharmacokinetics
  • Humans
  • Hyaluronic Acid / administration & dosage*
  • Hyaluronic Acid / chemistry
  • Hyaluronic Acid / pharmacokinetics
  • Intestinal Mucosa / chemistry
  • Jejunum
  • Lung / metabolism
  • Macrophages / metabolism
  • Male
  • Mice
  • Molecular Weight
  • Particle Size
  • RAW 264.7 Cells
  • Rats, Sprague-Dawley
  • Rats, Wistar

Substances

  • Drug Carriers
  • Ginsenosides
  • ginsenoside Rg3
  • Cellulose
  • Hyaluronic Acid
  • Chitosan
  • hydroxypropylcellulose